Skip to main content
Home

Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE),  American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA). 

RSS icon

  • Jupiter Endovascular's Vertex Pulmonary Embolectomy System showed positive results in its SPIRARE II pivotal trial.

    'Compelling' study shows promise of new pulmonary embolectomy system

    "Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. 

  • Video: Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, Icahn School of Medicine at Mount Sinai, explains studies on the latest pulsed field ablation and leadless conduction pacing trials. #PFA #conductionpacing

    Exploring the latest data in PFA and leadless conduction system pacing

    Vivek Reddy, MD, spoke to Cardiovascular Business about some of the biggest trends in electrophysiology today.

  • Samuel Jones, MD, MPH, director of inpatient electrophysiology at the Memorial Hospital, Chattanooga Heart Institute, discusses concerns over new heart failure Medicare Ambulatory Specialty Model payment model that starts on Jan. 1, 2027.

    Cardiologists scramble to prepare for mandatory heart failure payment model

    Samuel Jones, MD, reviews some of the biggest concerns about a new Medicare payment model focused on heart failure care that goes live in 2027. 

  • President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.

    Trump administration exempts doctors from work visa freeze

    SCAI said reversing the processing hold allows physicians to continue serving patients and helps stabilize the workforce.

  • Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, spoke with Cardiovascular Business at the Heart Rhythm 2026 meeting in the above video interview. She explained both the explosion of PFA use since the first FDA approvals in 2024, and the recently discovered complications of coronary vessel spasm and hemolysis and how newer PFA technology might address this.

    PFA has been a game-changer for heart patients—but there are still risks

    Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.

 Former American College of Cardiology president Hadley Wilson, MD, FACC, executive vice chair of Atrium Health's Sanger Heart and Vascular Institute, shared his thoughts on what he saw as the key studies in the above video interview with Cardiovascular Business. He covered numerous trials in more detail in the video. #ACC26 #ACC

Key clinical takeaways from ACC.26

Hadley Wilson, MD, a former American College of Cardiology president, spoke to Cardiovascular Business about several studies presented at ACC.26.

Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.

PCI before TAVR? In older CAD patients, deferral may be the best approach

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

Interventional cardiologist Roxana Mehran, MD, officially started her one-year term as the president of the American College of Cardiology (ACC) on the closing day of ACC.26, the group’s annual conference in New Orleans.

Interventional cardiologist Roxana Mehran elected ACC president

A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.

Adam Greenbaum, MD, presents late-breaking data at ACC.26.

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate. 

Divaka Perera, MD, at ACC.26

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26

Catheter-based treatment linked to major benefits for intermediate-risk PE

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  

heart ice cool cold freezing frozen

Cold weather responsible for many more stroke and heart attack deaths than heat

While heat consistently gets more attention in terms of public health messaging, new data show just how dangerous the cold can be.

Vascudyne's off-the-shelf conduit for CABG surgeries

New off-the-shelf conduit for CABG shows promise in first-in-human study

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …3
    • Page 4
    • Page 5
    • Page 6
    • Current page 7
    • Page 8
    • Page 9
    • Page 10
    • Page 11 …
    • Next page Next ›
    • Last page Last »
Displaying 49 - 56 of 1527
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme